Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension

HA Ghofrani, J Pepke-Zaba, JA Barbera… - Journal of the American …, 2004 - jacc.org
Pulmonary hypertension (PH) is a disease of various origins. Nitric oxide—a potent
vasodilator—is a key player of pulmonary vasoregulation. Nitric oxide signaling is mainly …
被引用次数：245 相关文章
[PDF] amazonaws.com

[PDF][PDF] Nitric Oxide Pathway and Phosphodiesterase Inhibitors in Pulmonary Arterial Hypertension

PAH PAH - Journal of the American College of …, 2004 - alatoldsite.s3.amazonaws.com
Pulmonary hypertension (PH) is a disease of various origins. Nitric oxide—a potent
vasodilator—is a key player of pulmonary vasoregulation. Nitric oxide signaling is mainly …
[HTML] sciencedirect.com

[HTML][HTML] Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension

HA Ghofrani, J Pepke-Zaba, JA Barbera… - Journal of the American …, 2004 - Elsevier
Pulmonary hypertension (PH) is a disease of various origins. Nitric oxide—a potent
vasodilator—is a key player of pulmonary vasoregulation. Nitric oxide signaling is mainly …

[引用][C] Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension

HA GHOFRANI, J PEPKE-ZABA… - Journal of the …, 2004 - pascal-francis.inist.fr
Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.

HA Ghofrani, J Pepke-Zaba, JA Barbera… - Journal of the …, 2004 - europepmc.org
Pulmonary hypertension (PH) is a disease of various origins. Nitric oxide-a potent
vasodilator-is a key player of pulmonary vasoregulation. Nitric oxide signaling is mainly …

Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension

HA Ghofrani, J Pepke-Zaba… - Journal of the …, 2004 - pubmed.ncbi.nlm.nih.gov
Pulmonary hypertension (PH) is a disease of various origins. Nitric oxide-a potent
vasodilator-is a key player of pulmonary vasoregulation. Nitric oxide signaling is mainly …

Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension

HA Ghofrani, J Pepke-Zaba, JA Barbera… - Journal of the American …, 2004 - infona.pl
Pulmonary hypertension (PH) is a disease of various origins. Nitric oxide—a potent
vasodilator—is a key player of pulmonary vasoregulation. Nitric oxide signaling is mainly …
[PDF] academia.edu

[PDF][PDF] Nitric Oxide Pathway and Phosphodiesterase Inhibitors in Pulmonary Arterial Hypertension

PAH PAH - Journal of the American College of Cardiology, 2004 - academia.edu
Pulmonary hypertension (PH) is a disease of various origins. Nitric oxide—a potent
vasodilator—is a key player of pulmonary vasoregulation. Nitric oxide signaling is mainly …

[引用][C] Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension

HA Ghofrani, J Pepke-Zaba, JA Barbera… - Journal of the American …, 2004 - cir.nii.ac.jp
Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
[PDF] core.ac.uk

[PDF][PDF] Nitric Oxide Pathway and Phosphodiesterase Inhibitors in Pulmonary Arterial Hypertension

PAH PAH - Journal of the American College of Cardiology, 2004 - core.ac.uk
Pulmonary hypertension (PH) is a disease of various origins. Nitric oxide—a potent
vasodilator—is a key player of pulmonary vasoregulation. Nitric oxide signaling is mainly …